GNPS - cheese cultures - E Pierce Jan 2018
Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive
ORGANISM(S): Food Fermentation Metagenome (ncbitaxon:1154581)
SUBMITTER: 
Rachel Dutton
PROVIDER: MSV000081949 | GNPS | Wed Jan 17 19:36:00 GMT 2018
REPOSITORIES: GNPS
Dataset's files
primary
| Action | DRS | |||
|---|---|---|---|---|
| MSV000081949 | Other | |||
| params.xml | Xml | |||
| Blk_no_inj_01.mzML | Mzml | |||
| Blk_no_inj_02.mzML | Mzml | |||
| Blk_no_inj_03.mzML | Mzml |
Items per page: 5 1 - 5 of 473 |
Similar Datasets
Project description:Small molecule analysis of cheese culture extracts, standard methanol extraction; iron limitation and additions. Data were acquired using a Thermo Q Exactive and C18 RP-UHPLC. Positive polarity acquisition of LC-MS/MS.
2019-05-16 | MSV000083791 | MassIVE
Project description:Liquid-chromatography coupled to high resolution mass spectrometry (LC-HRMS) is currently the method of choice for untargeted metabolomic analysis. The availability of established protocols to achieve a high confidence identification of metabolites is crucial. The aim of this work is to describe the workflow that we have applied to build an Accurate Mass Retention Time (AMRT) database using a commercial metabolite library of standards. LC-HRMS analysis was carried out using a Vanquish Horizon UHPLC system coupled to a Q-Exactive Plus Hybrid Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher Scientific, Milan, Italy). The fragmentation spectra, obtained with 12 collision energies, were acquired for each metabolite, in both polarities, through flow injection analysis. Several chromatographic conditions were tested to obtain a protocol that yielded stable retention times. The adopted chromatographic protocol included a gradient separation using a reversed phase (Waters Acquity BEH C18) and a HILIC (Waters Acquity BEH Amide) column. An AMRT database of 518 compounds was obtained and tested on real plasma and urine samples analyzed in data-dependent acquisition mode. Our AMRT library allowed a level 1 identification, according to the Metabolomics Standards Initiative, of 132 and 124 metabolites in human pediatric plasma and urine samples, respectively. This library represents a starting point for future metabolomic studies in pediatric settings.
| S-EPMC8303579 | BioStudies
Project description:Data was acquired using a Thermo Q-Exactive and C18 RP-UHPLC.
2018-01-18 | MSV000081952 | GNPS
Project description:Serum of LCMV infected mice. Data was generated on a Thermo Q Exactive and C18 RP UHPLC. Positive polarity acquisition on LC-MS/MS.
2019-11-12 | MSV000084576 | MassIVE
Project description:Six aristolochic acids were identified in the Chilean species <i>Aristolochia chilensis</i> using high-performance liquid chromatography coupled to a diode array detector (HPLC-DAD) and subsequent confirmation with mass spectrometry (MS). The fractions of each signal were collected and injected directly into an Orbitrap mass detector model Q Exactive Focus (Thermo Scientific). The acids extraction was done with 0.10-0.50?g of lyophilized and pulverized sample and concentrated in Soxhlet extraction equipment. The liquid-liquid separations and a subsequent solid phase extraction (SPE) C18 were performed using 100?<i>µ</i>L of the extract that contains the aristolochic acids present in the <i>Aristolochia chilensis</i> plant. The HPLC conditions used a single mobile phase acetonitrile?:?water (1?:?1) acidified with 0.1% acetic acid and an isocratic elution to 1?mL·min<sup>-1</sup>. The column InertSustain C18 250?×?4.6?mm and 3?<i>µ</i>m was used, the injection volume was 20?<i>µ</i>L, and the time of run was reduced to 15?min. Calibration curves were constructed with <i>r</i><sup>2</sup>?being 0.9997. The quantification limit for AAI was 0.138?±?0.010?<i>µ</i>g/mL, and for AAII, it was 0.558?±?0.042?<i>µ</i>g/mL.
| S-EPMC6011054 | BioStudies
Project description:The first set (dataset-1) included ten commercially available peptides (secretin, calcitonin, oxytocin, octreotide, deslorelin, histrelin, goserelin, buserelin, leuprolide and gonadorelin) and four marker substrate peptides with known cleavage sites as positive controls for each of the selected proteases - trypsin, chymotrypsin, pancreatic elastase and pepsin (Table 1). Five out of the ten compounds had unnatural amino acids and three of them were cyclic peptides. Moreover, to investigate the effect of small chemical/monomer changes in the peptide structure with respect to the proteases catalyzed reactions, the set was selected to also contain five synthetic analogues for the same peptide series, luteinizing-hormone releasing hormone (LHRH). All test compounds were prepared as a stock in concentration of 10 mM in dimethyl sulfoxide (DMSO).
For the second set of peptides (dataset-2) metabolite identification was performed for 4 commercially available peptides (glucagon-like peptide-1 (GLP-1) and 3 synthetic analogues for the GLP-1: taspoglutide, exenatide and liraglutide) for the selected proteases (Table 1). Taspoglutide peptide had non-natural amino acids and liraglutide had C-16 fatty acid side chain (palmitic acid). GLP-1, taspoglutide and exenatide were prepared as a stock in concentration of 10 mM and liraglutide was prepared in concentration of 5 mM in DMSO.
For the first dataset, chromatographic separation of metabolites was performed using the ACQUITY ultra-performance liquid chromatography (UPLC) system (Waters, Milford, MA, USA). The ACQUITY UPLC BEH C18 column. MS/MS analyses were run on a Thermo Scientific Q-Exactive Plus mass spectrometer operated in positive electrospray ionization (ESI) mode. MS/MS was a data dependent acquisition (DDA) using peptide specific inclusion lists containing amide hydrolysis ions of multiple charge states (z =1 to 3). Thermo Scientific Dionex UltiMate 3000 RS HPLC system in combination with a Pal autosampler (CTC Analytics AG, Zwingen, Switzerland was used. Chromatographic separation was performed using an Acquity CSHT Phenyl-Hexyl Column. MS/MS analyses were run on a Q Exactive? Hybrid Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher Scientific) operated in positive electrospray ionization (ESI) mode. MS/MS was a data dependent acquisition (DDA) using peptide specific inclusion lists containing amide hydrolysis ions of multiple charge states (z =1 to 5).
| S-BSST33 | BioStudies
Project description:Investigation of small molecules detected in bacterial inhibitory zone. Data were generated on a Thermo Q Exactive and C18 RP UHPLC. Positive polarity acquisition on LC-MS/MS.
2019-04-02 | MSV000083651 | MassIVE
Project description:Small molecule analysis of cheese culture extracts, standard methanol extraction; iron limitation and additions. Data were acquired using a Thermo Q Exactive and C18 RP-UHPLC. Positive polarity acquisition of LC-MS/MS.
2019-05-16 | MSV000083791 | GNPS
Project description:Genome-wide mapping of gene-microbiome interaction: implication in behavior and effect on microbiome and metabolome. Data was generated on a Thermo Q Exactive and C18 RP UHPLC. Positive polarity acquisition on LC-MS/MS.
2019-04-01 | MSV000083647 | MassIVE
Project description:Migraine is a chronic brain disease that leads to periodic neurological attacks. Parishin A and isorhynchophylline (PI) is the active monomer component extracted from the traditional antimigraine Chinese medicinal combination of Gastrodia and Uncaria, respectively. In this study, using high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS) technology, we performed pharmacokinetic and lipidomic study on migraine model rats after administration of PI. For the detection of the compounds in plasma, AB Sciex Triple Quad™ 4500 was applied for quantitative analysis, and the COSMOSIL C18 column (2.1?×?100?mm, 2.6??m) was used for separation. Isorhynchophylline (ISO: m/z 384.8-241.2) and its main metabolite rhynchophylline (RHY: m/z 384.8-160.2) were simultaneously detected under positive ion modes. Besides, parishin A (PA: m/z 995.1-726.9) and its main metabolite gastrodin (GAS: m/z 331.1-123.0) were simultaneously detected with negative ion modes. For the analysis of endogenous lipid components, Dionex Ultimate 3000 (UHPLC) Thermo Orbitrap Elite was applied for the detection, and the Waters UPLCRBEH C18 column (1.7??m 100???2.1?mm) was used for separation. Chloroform/methanol (2?:?1, v?:?v) was used for extraction. The results demonstrated that PI exists significant difference in metabolism between single- and coadministration and can regulate lipid levels associated with migraine.
| S-EPMC7362284 | BioStudies